Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B J van Zwieten

Showing results (1-10 of 10) with videos related to

Pageof 1
Sort By:
European Journal of Pharmacology|September 1, 1975
The effect of blocking dopamine release on synthesis rate of dopamine in the striatum of the ratB J Van Zwieten-Boot, E L Noach
European Journal of Pharmacology|October 1, 1976
Absence of a 'cholinergic link' in the apomorphine-induced feedback inhibition of dopamine synthesis in rat striatumB J Van Zwieten-Boot, A Petri-Bot
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|February 3, 1999
Schizophrenia: do we really need placebo-controlled studies?J G Storosum, A J Elferink, B J van Zwieten
International Journal of Clinical Pharmacology and Therapeutics|October 3, 2007
Are women appropriately represented and assessed in clinical trials submitted for marketing authorization? A review of the database of the European Medicines AgencyM Müllner, S Vamvakas, M Rietschel, et al.
Nederlands Tijdschrift Voor Geneeskunde|October 23, 2004
[Severe adverse reactions after the use of sulphur hexafluoride (SonoVue) as an ultrasonographic contrast agent]M C H de Groot, B J van Zwieten-Boot, A C van Grootheest
Pharmacopsychiatry|January 30, 2004
Natural course and placebo response in short-term, placebo-controlled studies in major depression: a meta-analysis of published and non-published studiesJ G Storosum, A J Elferink, B J van Zwieten, et al.
European Psychiatry : the Journal of the Association of European Psychiatrists|October 5, 2001
Relapse and recurrence prevention in major depression: a critical review of placebo-controlled efficacy studies with special emphasis on methodological issuesJ G Storosum, B J van Zwieten, H D Vermeulen, et al.
The American Journal of Psychiatry|August 2, 2001
Suicide risk in placebo-controlled studies of major depressionJ G Storosum, B J van Zwieten, W van den Brink, et al.
Nederlands Tijdschrift Voor Geneeskunde|May 17, 2000
[Clinical evaluation of efficacy and adverse effects in the (European) registration of drugs: what does it mean for the doctor and patient?]P P Koopmans, P A de Graeff, B J van Zwieten-Boot, et al.
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|April 21, 2001
Short-term efficacy of tricyclic antidepressants revisited: a meta-analytic studyJ G Storosum, A J Elferink, B J van Zwieten, et al.
Pageof 1

Showing results (1-10 of 10) with videos related to

Sort By:
Pageof 1
European Journal of Pharmacology|September 1, 1975
The effect of blocking dopamine release on synthesis rate of dopamine in the striatum of the ratB J Van Zwieten-Boot, E L Noach
European Journal of Pharmacology|October 1, 1976
Absence of a 'cholinergic link' in the apomorphine-induced feedback inhibition of dopamine synthesis in rat striatumB J Van Zwieten-Boot, A Petri-Bot
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|February 3, 1999
Schizophrenia: do we really need placebo-controlled studies?J G Storosum, A J Elferink, B J van Zwieten
International Journal of Clinical Pharmacology and Therapeutics|October 3, 2007
Are women appropriately represented and assessed in clinical trials submitted for marketing authorization? A review of the database of the European Medicines AgencyM Müllner, S Vamvakas, M Rietschel, et al.
Nederlands Tijdschrift Voor Geneeskunde|October 23, 2004
[Severe adverse reactions after the use of sulphur hexafluoride (SonoVue) as an ultrasonographic contrast agent]M C H de Groot, B J van Zwieten-Boot, A C van Grootheest
Pharmacopsychiatry|January 30, 2004
Natural course and placebo response in short-term, placebo-controlled studies in major depression: a meta-analysis of published and non-published studiesJ G Storosum, A J Elferink, B J van Zwieten, et al.
European Psychiatry : the Journal of the Association of European Psychiatrists|October 5, 2001
Relapse and recurrence prevention in major depression: a critical review of placebo-controlled efficacy studies with special emphasis on methodological issuesJ G Storosum, B J van Zwieten, H D Vermeulen, et al.
The American Journal of Psychiatry|August 2, 2001
Suicide risk in placebo-controlled studies of major depressionJ G Storosum, B J van Zwieten, W van den Brink, et al.
Nederlands Tijdschrift Voor Geneeskunde|May 17, 2000
[Clinical evaluation of efficacy and adverse effects in the (European) registration of drugs: what does it mean for the doctor and patient?]P P Koopmans, P A de Graeff, B J van Zwieten-Boot, et al.
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|April 21, 2001
Short-term efficacy of tricyclic antidepressants revisited: a meta-analytic studyJ G Storosum, A J Elferink, B J van Zwieten, et al.
Pageof 1